Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Long-lasting, low toxicity antimicrobial peptide fights 'superbug' lung infections

Researchers considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria.

1 May 2020

TTP plc collaborates with ODx to develop new technology to address antibiotic resistance

TTP plc has announced today that it has partnered with ODx, a company committed to developing a system for assessing urinary tract infections (UTIs).

From TTP plc 30 Apr 2020

FMT improves clinical outcomes in extremely ill patients with drug-resistant bacteria

Transferring fecal matter from the digestive systems of healthy donors to extremely ill patients who had previously been infected with drug-resistant bacteria resulted in shorter hospital stays, fewer bloodstream infections and infections that were easier to treat, according to research that was selected for presentation at Digestive Disease Week 2020.

30 Apr 2020

New clinical trial launched to study if convalescent plasma can treat COVID-19

Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma- taken from people who have recovered from COVID-19 - is effective in treating the disease.

29 Apr 2020

Universal childhood vaccination could prevent antimicrobial resistance

A new study from the University of California, Berkeley, published in the journal Nature in April 2020, reports that extending vaccination to all children could help resolve antimicrobial resistance - one of the biggest obstacles to effective healthcare in low-income countries. This is the first study to look at how vaccination is related to the use of antibiotics in low- and middle-income countries.

29 Apr 2020

Venatorx and GARDP collaborate to accelerate development of new antibiotic

Venatorx Pharmaceuticals and the Global Antibiotic Research and Development Partnership (GARDP) today announced a collaboration to accelerate the development of, and access to, cefepime-taniborbactam (formerly cefepime/VNRX-5133).

29 Apr 2020

Antibiotic exposure and its priming effect on disease-causing bacteria

Antibiotics save lives -- but using them also helps antibiotic-resistant strains evolve and spread. Each year, antibiotic-resistant bacteria infect some 2.8 million people in the United States, killing more than 35,000, according to the Centers for Disease Control and Prevention.

27 Apr 2020

Rice University looks to ‘trap and zap’ SARS-CoV-2 in wastewater

A team of researchers from Rice University has won a National Science Foundation (NSF) RAPID grant to adapt their wastewater nanotechnology project to help trap and inactivate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), (which causes COVID-19 disease), in wastewater. This could help public health officials deal with the threat of disease transmission through wastewater.

27 Apr 2020

Early Heparin therapy improves hypoxia in COVID-19 patients

The systemic use of heparin for treating severe coronavirus disease (COVID-19) showed significant improvements in oxygen exchange and overall clinical presentation of patients, as reported by a study from Brazil available on a preprint server medRxiv.

26 Apr 2020

Researchers demonstrate how TB bacteria import vitamin B12 molecules to grow

Researchers from Russia, the Netherlands, Sweden, and the U.S. have revealed the structure of the protein responsible for vitamin B12 import into the cells of the bacterium that causes tuberculosis. The research findings were published in Nature.

23 Apr 2020

Study shows new diagnostic option for catching degenerative eye disease in its earliest stages

A paper published in the Journal of Biomedical Optics (JBO), "Imaging hydroxyapatite in sub-retinal pigment epithelial deposits by fluorescence lifetime imaging microscopy with tetracycline staining," demonstrates a potential new diagnostic option for catching a degenerative eye disease in its earliest stages.

22 Apr 2020

New database of 14,000 known macrolactones could support drug discovery and research

Researchers from North Carolina State University and Collaborations Pharmaceuticals have created a free-to-use database of 14,000 known macrolactones - large molecules used in drug development - which contains information about the molecular characteristics, chemical diversity and biological activities of this structural class.

22 Apr 2020

Research: Peptide makes older antibiotics effective again at doses 100 times lower than usual

A peptide renders older antibiotics effective again at doses 100 times lower than the common dosage, as shown by research from örebro University.

22 Apr 2020

Raw-type dog food contains high levels of multidrug-resistant bacteria

Microorganisms that infect animals, such as dogs, have the potential to jump to humans and cause illness. Zoonosis is a disease that can spread from animals to humans. These diseases pose health risks, mainly that some types can become life-threatening. Now, a study warns that raw-type dog food contains high levels of multidrug-resistant bacteria, which has the potential of transmitting the bacteria between dogs and humans.

21 Apr 2020

Study shows it is safe to give antibiotics to mothers after umbilical cord clamping in C-sections, to avoid exposure of newborns

Research shows it is safe to give antibiotics to mothers after umbilical clamping in C section, to avoid exposure of the baby.

17 Apr 2020

New insights into the building blocks of periodontitis

Porphyromonas gingivalis is a major bacterial pathogen which leads to periodontitis also known as gum disease. In Japan, 80% of adults aged 35 and over suffer from this disease. What's more, P. gingivalis has also been linked to rheumatoid arthritis, cardiovascular disease, pancreatic cancer, and even Alzheimer's disease.

13 Apr 2020

Intermountain Healthcare and University of Utah Health launch two COVID-19 clinical trials

Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs - hydroxychloroquine and azithromycin - to treat patients with COVID-19.

13 Apr 2020

Antibiotic News and Research

Further Reading

Long-lasting, low toxicity antimicrobial peptide fights 'superbug' lung infections

TTP plc collaborates with ODx to develop new technology to address antibiotic resistance

FMT improves clinical outcomes in extremely ill patients with drug-resistant bacteria

New clinical trial launched to study if convalescent plasma can treat COVID-19

Universal childhood vaccination could prevent antimicrobial resistance

Venatorx and GARDP collaborate to accelerate development of new antibiotic

Antibiotic exposure and its priming effect on disease-causing bacteria

Rice University looks to ‘trap and zap’ SARS-CoV-2 in wastewater

Early Heparin therapy improves hypoxia in COVID-19 patients

Researchers demonstrate how TB bacteria import vitamin B12 molecules to grow

Study shows new diagnostic option for catching degenerative eye disease in its earliest stages

New database of 14,000 known macrolactones could support drug discovery and research

Research: Peptide makes older antibiotics effective again at doses 100 times lower than usual

Raw-type dog food contains high levels of multidrug-resistant bacteria

Study shows it is safe to give antibiotics to mothers after umbilical cord clamping in C-sections, to avoid exposure of newborns

New insights into the building blocks of periodontitis

Intermountain Healthcare and University of Utah Health launch two COVID-19 clinical trials

The building blocks of gum disease

Lasers turn metal surfaces into bacteria killers

Study: Bangladesh’s surface waters have high levels of antibiotic residues, chemicals

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News